Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meetings, 68875-68876 [2024-19294]

Download as PDF Federal Register / Vol. 89, No. 167 / Wednesday, August 28, 2024 / Notices 68875 QEF'Et,1$£ $E<;URITY<;C)011'ERA!IONAGENCY • • 2800 - - - - P e ~ Washlnaton,DC:20301..2800 November 8, 2022 The Honorable Nancy Pefosl Speaker of the House u.s. House of Representatives H-209,·The.CapitQl Washington. PC 20Sl5 Dear Madam Speaker. ~ t t o the rept)rt1ng requirements of $ection 36(b)(l) of.the Amis Export Control Act tts am~nded, we are forwarding herewith TnmsmittafNo. 22-63. eoncemmi the Air FQtccfs ~ Letrer(s) of Offer and Acceptance to the Oovernm,entofBelgium for defense articles and er\iices estimated to cost $380 million; After this letter is delivered to your officet we ptan toissue a news release to notify the pubtfo of this proposed safo, Sincerely, ~a-~ /James A. Bursch Director Enclosures: L Transmittal 2, Policy Justification . :3. Sensitivity ofTechnology BILLING CODE 0099–10–C Open to the public, Wednesday, September 25th, 2024, 10:00 a.m.–1:00 p.m. Eastern Standard Time (EST). Wednesday, December 18th, 2024, 10:00 a.m.–1:00 p.m. EST. DATES: DEPARTMENT OF DEFENSE Office of the Secretary khammond on DSKJM1Z7X2PROD with NOTICES Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meetings Under Secretary of Defense for Personnel and Readiness, Department of Defense (DoD). ACTION: Notice of Federal advisory committee meetings. The DoD is publishing this notice to announce the following Federal Advisory Committee meetings VerDate Sep<11>2014 18:13 Aug 27, 2024 Jkt 262001 The meetings will be held telephonically or via conference call. The phone number for the remote access is CONUS: 1–888–831–4306; OCONUS: 1–210–234–8694; PARTICIPANT CODE: 9136304. These numbers and the dial-in instructions will also be posted on the UFBAP website at: https:// www.health.mil/Military-Health-Topics/ ADDRESSES: AGENCY: SUMMARY: of the Uniform Formulary Beneficiary Advisory Panel (UFBAP) will take place. PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 Access-Cost-Quality-and-Safety/ Pharmacy-Operations/BAP. FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO) Captain Tiffany F. Cline, USN, 703– 681–2890 (voice), dha.ncr.j6.mbx.baprequests@health.mil (email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Website: https:// www.health.mil/Military-Health-Topics/ Access-Cost-Quality-and-Safety/ Pharmacy-Operations/BAP. The most up-to-date changes to the meeting agendas can be found on the website. These meetings are being held under the provisions of chapter 10 of title 5, United States Code (U.S.C.) (commonly SUPPLEMENTARY INFORMATION: E:\FR\FM\28AUN1.SGM 28AUN1 EN28AU24.402</GPH> [FR Doc. C1–2024–18294 Filed 8–27–24; 8:45 am] 68876 Federal Register / Vol. 89, No. 167 / Wednesday, August 28, 2024 / Notices khammond on DSKJM1Z7X2PROD with NOTICES known as the ‘‘Federal Advisory Committee Act’’ or ‘‘FACA’’) and 41 Code of Federal Regulations (CFR) 102– 3.140 and 102–3.150. Purpose of the Meetings: The UFBAP will review and comment on recommendations made by the Pharmacy and Therapeutics Committee to the Director, Defense Health Agency regarding the Uniform Formulary. Agenda: Both the September 25, 2024 and the December 18, 2024 meetings will follow the same agenda. 1. 10:00 a.m.–10:10 a.m. Sign in for UFBAP members 2. 10:10 a.m.–10:40 a.m. Welcome and Opening Remarks a. Welcome, Opening Remarks, and Introduction of UFBAP Members by CAPT Tiffany F. Cline, DFO, UFBAP b. Public Written Comments by CAPT Tiffany F. Cline, DFO, UFBAP c. Opening Remarks by Dr. Pamela Schweitzer, UFBAP Chair d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary Management Branch 3. 10:40 a.m.–11:45 a.m. Scheduled Therapeutic Class Reviews 4. 11:45 a.m.–12:30 p.m. Newly Approved Drugs Review 5. 12:30 p.m.–12:45 p.m. Pertinent Utilization Management Issues 6. 12:45 p.m.–1:00 p.m. Closing remarks a. Closing Remarks by UFBAP CoChair VerDate Sep<11>2014 18:13 Aug 27, 2024 Jkt 262001 b. Closing Remarks by DFO, UFBAP Meeting Accessibility: Pursuant to 5 U.S.C. 1009(a)(1) and 41 CFR 102–3.140 through 102–3.165, and subject to the availability of phone lines, the meetings are open to the public. Telephone lines are limited and available to the first 220 people dialing in. There will be 220 lines total: 200 domestic and 20 international, including leader lines. Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140(c), and 5 U.S.C. 1009(a)(3), interested persons or organizations may submit written statements to the UFBAP about its mission and/or the agenda to be addressed in the public meetings. Written statements should be submitted to the UFBAP’s DFO. The DFO’s contact information can be found in the FOR FURTHER INFORMATION CONTACT section of this notice. Written comments or statements must be received by the UFBAP’s DFO at least five (5) calendar days prior to a meeting so they may be made available to the UFBAP for its consideration prior to a meeting. Written comments received are releasable to the public. The DFO will review all submitted written statements and provide copies to UFBAP. DEPARTMENT OF DEFENSE Dated: August 21, 2024. Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. Aaron T. Siegel, [FR Doc. 2024–19294 Filed 8–27–24; 8:45 am] Office of the Secretary [Transmittal No. 23–05] Arms Sales Notification Defense Security Cooperation Agency, Department of Defense (DoD). AGENCY: ACTION: Arms sales notice. The DoD is publishing the unclassified text of an arms sales notification. SUMMARY: Neil Hedlund at neil.g.hedlund.civ@mail.mil or (703) 697–9214. FOR FURTHER INFORMATION CONTACT: This 36(b)(1) arms sales notification is published to fulfill the requirements of section 155 of Public Law 104–164 dated July 21, 1996. The following is a copy of a letter to the Speaker of the House of Representatives with attached Transmittal 23–05 and Policy Justification. SUPPLEMENTARY INFORMATION: Dated: August 23, 2024. Alternate OSD Federal Register Liaison Officer, Department of Defense. BILLING CODE 6001–FR–P BILLING CODE 6001–FR–P PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\28AUN1.SGM 28AUN1

Agencies

[Federal Register Volume 89, Number 167 (Wednesday, August 28, 2024)]
[Notices]
[Pages 68875-68876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19294]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Meetings

AGENCY: Under Secretary of Defense for Personnel and Readiness, 
Department of Defense (DoD).

ACTION: Notice of Federal advisory committee meetings.

-----------------------------------------------------------------------

SUMMARY: The DoD is publishing this notice to announce the following 
Federal Advisory Committee meetings of the Uniform Formulary 
Beneficiary Advisory Panel (UFBAP) will take place.

DATES: Open to the public, Wednesday, September 25th, 2024, 10:00 a.m.-
1:00 p.m. Eastern Standard Time (EST). Wednesday, December 18th, 2024, 
10:00 a.m.-1:00 p.m. EST.

ADDRESSES: The meetings will be held telephonically or via conference 
call. The phone number for the remote access is CONUS: 1-888-831-4306; 
OCONUS: 1-210-234-8694; PARTICIPANT CODE: 9136304.
    These numbers and the dial-in instructions will also be posted on 
the UFBAP website at: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP.

FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO) 
Captain Tiffany F. Cline, USN, 703-681-2890 (voice), [email protected] (email). Mailing address is 7700 Arlington 
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP. The most up-to-date changes to the meeting 
agendas can be found on the website.

SUPPLEMENTARY INFORMATION: These meetings are being held under the 
provisions of chapter 10 of title 5, United States Code (U.S.C.) 
(commonly

[[Page 68876]]

known as the ``Federal Advisory Committee Act'' or ``FACA'') and 41 
Code of Federal Regulations (CFR) 102-3.140 and 102-3.150.
    Purpose of the Meetings: The UFBAP will review and comment on 
recommendations made by the Pharmacy and Therapeutics Committee to the 
Director, Defense Health Agency regarding the Uniform Formulary.
    Agenda: Both the September 25, 2024 and the December 18, 2024 
meetings will follow the same agenda.

1. 10:00 a.m.-10:10 a.m. Sign in for UFBAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
    a. Welcome, Opening Remarks, and Introduction of UFBAP Members by 
CAPT Tiffany F. Cline, DFO, UFBAP
    b. Public Written Comments by CAPT Tiffany F. Cline, DFO, UFBAP
    c. Opening Remarks by Dr. Pamela Schweitzer, UFBAP Chair
    d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary 
Management Branch
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues
6. 12:45 p.m.-1:00 p.m. Closing remarks
    a. Closing Remarks by UFBAP Co-Chair
    b. Closing Remarks by DFO, UFBAP

    Meeting Accessibility: Pursuant to 5 U.S.C. 1009(a)(1) and 41 CFR 
102-3.140 through 102-3.165, and subject to the availability of phone 
lines, the meetings are open to the public. Telephone lines are limited 
and available to the first 220 people dialing in. There will be 220 
lines total: 200 domestic and 20 international, including leader lines.
    Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-
3.140(c), and 5 U.S.C. 1009(a)(3), interested persons or organizations 
may submit written statements to the UFBAP about its mission and/or the 
agenda to be addressed in the public meetings. Written statements 
should be submitted to the UFBAP's DFO. The DFO's contact information 
can be found in the FOR FURTHER INFORMATION CONTACT section of this 
notice. Written comments or statements must be received by the UFBAP's 
DFO at least five (5) calendar days prior to a meeting so they may be 
made available to the UFBAP for its consideration prior to a meeting. 
Written comments received are releasable to the public. The DFO will 
review all submitted written statements and provide copies to UFBAP.

    Dated: August 21, 2024.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2024-19294 Filed 8-27-24; 8:45 am]
BILLING CODE 6001-FR-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.